Sheryl Huggins Salomon - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Sheryl Huggins Salomon's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists todaySheryl Huggins Salomon
Verified
Contributing Editor, City & State NY
New York
Beats
Biography
Sheryl is a contributing health writer for Everyday Health, where her work has received silver and bronze Digital Health Awards; as well as the advisory board chair for City & State New York, which covers NYS/NYC politics. She has been a contributing health writer for Livestrong.com, and an alum of The Root, NewsOne, AOL, The Washington Post Company, Dow Jones Newswires, Fortune Small Business (FSB.com) and Columbia Journalism School. She sits on the executive council of The Deadline Club - Society of Professional Journalists, New York.
Skin Diseases , Health Topics , Racial Health Disparities , Metabolic Health , Diabetes , Nutrition
Beauty, health, politics
Content
By Sheryl Huggins Salomon| Everyday Health Verified You may have noticed a new phrase on the packaging of your favorite breakfast flakes or crispy snacks: “Contains a bioengineered food ingredient." That’s because since January 2022, the U.S. Department of Agriculture (USDA) has required this language to be displayed on the packaging of some products that contain substances called “genetically engineered ingredients,” “genetically modified organisms,” or, as they're more commonly known, “GMOs.” A GMO is a food or crop with genetic material
By Sheryl Huggins Salomon| Everyday Health Verified If you’re managing type 2 diabetes, you might wonder if the new headline-making injectable drugs with weight loss benefits are right for you
By Sheryl Huggins Salomon| Everyday Health Verified Tirzepatide (manufactured by Eli Lilly with the brand name, Mounjaro) is the first Food and Drug Administration (FDA)-approved drug that is part of a brand-new drug class called glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, or GLP-1 and GIP receptor agonists for short. Tirzapetide is administered as a once-weekly injection under the skin of your abdomen, thigh, or upper arm using a pre-filled pen, according to Eli Lilly
Company Info
City & State NY
City & State New York is a multimedia news organization focused on non-partisan coverage of local and state politics, policy, and government in New York and Pennsylvania. Founded by Tom Allon, the company is part of the Government Executive Media Group following its acquisition in 2021. It serves as a vital platform for political leaders, providing insights into legislative developments and policy debates. The organization offers a weekly print magazine and daily digital content, including the *First Read* email briefing, which features legislative updates and election analysis. City & State also hosts events such as forums and award ceremonies to connect government and business leaders. Additionally, it produces podcasts and multimedia content, including interviews and commentary. With plans for expansion into new markets like California, Florida, and Texas, City & State continues to inform decision-makers in both government and the private sector.
'+1 212-268-0442
Founded: 2006